We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease ... Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). Show more
Topline Data from CAHmelia-204 Study of Tildacerfont in Adult Congenital Adrenal Hyperplasia (CAH) Anticipated in December 2024 Topline Data from CAHptain-205 Study of Tildacerfont in Adult and...
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant...
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant...
Announced Strategic Collaboration with HMNC Brain Health GmbH (HMNC) to Develop Tildacerfont for the Treatment of Major Depressive Disorder (MDD) Topline Data from CAHmelia-204 Study of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0244 | -4.80882932598 | 0.5074 | 0.5169 | 0.4726 | 233554 | 0.48501288 | CS |
4 | -0.097 | -16.724137931 | 0.58 | 0.6049 | 0.4726 | 320101 | 0.54023185 | CS |
12 | 0.0229 | 4.97717887416 | 0.4601 | 0.608 | 0.42 | 395640 | 0.49260382 | CS |
26 | -0.2859 | -37.1829886851 | 0.7689 | 0.7689 | 0.41115 | 432516 | 0.53117667 | CS |
52 | -0.907 | -65.2517985612 | 1.39 | 5.95 | 0.41115 | 618138 | 1.2187933 | CS |
156 | -2.467 | -83.6271186441 | 2.95 | 5.95 | 0.41115 | 715157 | 2.94948385 | CS |
260 | -16.517 | -97.1588235294 | 17 | 35.6 | 0.41115 | 541225 | 3.38610396 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions